Extended use of the intrauterine device: A literature review and recommendations for clinical practice

Contraception

Volumn 89, Issue 6, 2014, Pages 495-503

  Wu, Justine P ^a   Pickle, Sarah ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Copper IUD; Copper T; Extended use; Intrauterine device; Levonorgestrel intrauterine system; LNG IUS; Prolonged use

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL; MULTILOAD COPPER INTRAUTERINE DEVICE; COPPER;

ARTICLE; CLINICAL PRACTICE; INTRAUTERINE CONTRACEPTIVE DEVICE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MENOPAUSE; OBESITY; PATIENT COUNSELING; PREGNANCY; PREGNANCY OUTCOME; UNPLANNED PREGNANCY; CASE STUDY; CONSENSUS; COUNSELING; FEMALE; FOLLOW UP; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); MULTILOAD COPPER INTRAUTERINE DEVICE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; UNITED NATIONS; WORLD HEALTH ORGANIZATION; ADVERSE EFFECTS; AGE; COMPARATIVE STUDY; COPPER INTRAUTERINE DEVICE; EDUCATION; EVIDENCE BASED MEDICINE; PACKAGING; PATIENT EDUCATION; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; WOMEN'S HEALTH;

AGE FACTORS; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HUMANS; INDIVIDUALIZED MEDICINE; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY RATE; PRODUCT LABELING; WOMEN'S HEALTH;

EID: 84901605496     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.02.011     Document Type: Review

References (55)

1. A. Sonfield Population disparity: attitudes about The IUD in Europe and the United States Guttmacher Policy Rev 10 2007 19 24
2. M.M.S.R. Ali, J. Cleland, T.D. Ngo, and I.H. Shah Long-term contraception protection, discontinuation and switching behavior: intrauterine device (IUD) use dynamics in 14 developing countries 2011 World Health Organization and Marie Stopes International London
3. J. Trussell Update on and correction to the cost-effectiveness of contraceptives in the United States Contraception 85 6 2012 611
4. T.M. Farley, M.J. Rosenberg, and P.J. Rowe et al. Intrauterine devices and pelvic inflammatory disease: an international perspective Lancet 339 1992 785 788
5. Mechanism of action, safety and efficacy of intrauterine devices. Report of a WHO Scientific Group. World Health Technical Report Series, 1987:1-91.
6. P.A. O'Brien, R. Kulier, and F.M. Helmerhorst et al. Copper-containing, framed intrauterine devices for contraception: a systematic review of randomized controlled trials Contraception 77 5 2008 318 327
7. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial Contraception 49 1 1994 56 72 (Pubitemid 24077388)
8. I. Sivin, S. el Mahgoub, and T. McCarthy et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study Contraception 42 4 1990 361 378 (Pubitemid 20312978)
9. L. Bahamondes, A. Faundes, and B. Sobreira-Lima et al. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age Contraception 72 5 2005 337 341 (Pubitemid 41503129)
10. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C Contraception 56 6 1997 341 352
11. I. Sivin Utility and drawbacks of continuous use of a copper T IUD for 20 years Contraception 75 6 Suppl 2007 S70 S75
12. Improving the safety and effectiveness of contraception in China: a case-study in promotion and improvement of family planning. UNDP/UNFPA/WHO/WORLD BANK Special Programme of Research, Development and Research Training in Human Reproduction (HRP). Geneva, Switzerland, 2008:20-24.
13. GyneFix® Prescribing information. Acessed January 25, 2014 at: http://contrel.be/GYNEFIX%20SPECIALISTS/prescribing-information.htm.
14. O. Meirik, P.J. Rowe, and A. Peregoudov et al. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial Contraception 80 2 2009 133 141
15. X. Cao, W. Zhang, and G. Gao et al. Randomized comparative trial in parous women of the frameless GyneFix and the TCu380A intrauterine devices: long-term experience in a Chinese family planning clinic Eur J Contracept Reprod Health Care 5 2 2000 135 140 (Pubitemid 30470065)
16. I.C. Chi The multiload IUD - a U.S. researcher's evaluation of a European device Contraception 46 5 1992 407 425
17. Multiload® Cu250/ Cu375. Consumer Medicine Information. Accessed January 25, 2014 at: http://www.mydr.com.au/webroot/cmis/OutXHTML/CM07006.htm.
18. Reproduction annual technical report: World Health Organization. Department of Reproductive Health and Research, including UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. 2003:59-60.
19. A randomized multicentre trial of the Multiload 375 and TCu380A IUDs in parous women: three-year results. UNDP/UNFPA/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction: IUD Research Group Contraception 49 6 1994 543 549
20. T. McCarthy, L. Ramachandran, and S.S. Ratnam Interim 4-year results of a comparative study between the Nova T and the Multiload 250 Adv Contracept 3 4 1987 323 326 (Pubitemid 18025631)
21. R. Soeprono Extended use of the Multiload Cu-250 Adv Contracept 4 2 1988 109 113
22. J. Diaz, A. Faundes, and M. Diaz et al. Evaluation of the clinical performance of a levonorgestrel releasing IUD, up to seven years of use, in Campinas Braz Contracept 47 2 1993 169 175 (Pubitemid 23062256)
23. M.M. Hidalgo, C. Hidalgo-Regina, and M.V. Bahamondes et al. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system Contraception 80 1 2009 84 89
24. I. Sivin, J. Stern, and E. Coutinho et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS Contraception 44 5 1991 473 480
25. M. Ronnerdag, and V. Odlind Health effects of long-term use of the intrauterine levonorgestrel releasing system. A follow-up study over 12 years of continuous use Acta Obstet Gynecol Scand 78 8 1999 716 721 (Pubitemid 29392677)
26. J. Bastidas, E. Cano, and N. Mora Copper corrosion-simulated uterine solutions Contraception 61 2000 395 399 (Pubitemid 30665816)
27. D. Edelman, and W. van Os Duration of use of copper releasing IUD and the incidence of copper wire breakage Eur J Gynecol Reprod Biol 34 1990 267 272 (Pubitemid 20056292)
28. B. Kaneshiro, and T. Aeby Long-term safety, efficacy, and patient acceptaibility of the intrauterine Copper T-380A contraceptive device Int J Womens Health 2 2010 211 220
29. M. Ortiz, and H. Croxatto Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action Contraception 75 2007 S16 S30
30. H. Timonen Copper release from copper-T intrauterine devices Contraception 14 1976 25 38
31. J. Gao, Y. Li, and J.-p. Liu et al. Releasing of cupric ion of three types of copper-bearing intrauterine contraceptive device in simulated uterine fluid J Reprod Contracept 18 2007 33 40
32. K. Hagenfeldt Influence on protein and copper concentrations and enzyme activities in uterine washings Contraception 6 1972 219 230
33. X. Zhou, Y. Li, and X. Jiang et al. Release of copper and indomethacin from intrauterine devices immersed in simulated uterine fluid Eur J Contracep Repr 15 3 2010 205 212
34. B. Cao, T. Xi, and Y. Zheng Release behavior of cupric ions for TCu380A and TCu220C IUDs Biomed Mater 3 4 2008 044114
35. F. Alvarez, P.L. Schilardi, and M.F. de Mele Reduction of the "burst release" of copper ions from copper-based intrauterine devices by organic inhibitors Contraception 85 1 2012 91 98
36. C.X.N. Zhang, and B. Yang The corrosion behaviour of copper in simulated uterine fluid Corros Sci 38 1996 635 641 (Pubitemid 126398739)
37. V. Arancibia, C. Peñab, and H. Allenc et al. Characterization of copper in uterine fluids of patients who use the copper T-380A intrauterine device Clin Chim Acta 332 2003 69 78 (Pubitemid 36577491)
38. A. Sedlis, E. Kandemire, and M. Stone Intrauterine pH of women using stainless steel contraceptive device Obstet Gynecol 30 1 1967 114 117
39. N. Mora, E. Cano, and E.M. Mora et al. Influence of pH and oxygen on copper corrosion in simulated uterine fluid Biomaterials 23 2002 667 671 (Pubitemid 33108943)
40. D. Wildemeersch New frameless and framed intrauterine devices and systems - an overview Contraception 75 6 Suppl 2007 S82 S92
41. A. Kjaer, K. Laursen, and L. Thormann et al. Copper release from copper intrauterine devices removed after up to 8 years of use Contraception 47 4 1993 349 358 (Pubitemid 23119417)
42. Mirena [package insert] 2013 Bayer HealthCare Pharmaceuticals Wayne, NJ
43. C.G. Nilsson, P.L. Lahteenmaki, and T. Luukkainen et al. Sustained intrauterine release of levonorgestrel over five years Fertil Steril 45 6 1986 805 807 (Pubitemid 16090188)
44. B.L. Xiao, L.Y. Zhou, and X.L. Zhang et al. Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device Contraception 41 4 1990 353 362
45. M.F. Natavio, D. Taylor, and R.A. Lewis et al. Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine system Contraception 87 4 2013 426 431
46. C.G. Nilsson, M. Haukkamaa, and H. Vierola et al. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD Clin Endocrinol 17 6 1982 529 536 (Pubitemid 12006959)
47. B. Seeber, S.C. Ziehr, and A. Gschliesser et al. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system Contraception 86 4 2012 345 349
48. G. Farr, R. Amatya, and M. Acosta et al. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries Contraception 52 1 1995 17 22
49. L. Dafni, A. Tamir, and T. Spenser et al. Long term use of inert intrauterine contraceptive devices in 94 women in Israel Br J Gen Pract 42 363 1992 423 425
50. M.E. Ortiz, H.B. Croxatto, and C.W. Bardin Mechanisms of action of intrauterine devices Obstet Gynecol Survey 51 12 Suppl 1996 S42 S51
51. United States Census Bureau. International Database. Fertility Rates, 2012. Accessed on February 14, 2013 at: http://www.census.gov/population/ international/data/idb/region.php?N=%20Results%20&T=9 A=aggregate&RT= 0&Y=2012&R=101,102&C.
52. T. Behringer, M.F. Reeves, and B. Rossiter et al. Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women Contraception 84 5 2011 e5 e10
53. I. Sivin, and J. Stern Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970-75 Stud Fam Plann 10 10 1979 263 281 (Pubitemid 10126355)
54. C. Dehlendorf, K. Levy, and A. Kelley et al. Women's preferences for contraceptive counseling and decision making Contraception 88 2 2013 250 256
55. M.H. Ebell, J. Siwek, B.D. Weiss, S.H. Woolf, J. Susman, and B. Ewigman et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature Am Fam Physiciaion 69 3 2004 548 556 (Pubitemid 38176273)